The findings showed lower risks of death, intensive care unit admission, and need for ventilation among Paxlovid recipients.
Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Genetic vulnerability, air pollution may raise risk of COVID infection, severe outcomes
- COVID 2024-25 vaccines 33% protective against emergency room or urgent care visits, data reveal
- Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
- US flu season shows signs of peak